Literature DB >> 26983075

Leveraging a Redesigned Morbidity and Mortality Conference That Incorporates the Clinical and Educational Missions of Improving Quality and Patient Safety.

Darlene B Tad-Y1, Read G Pierce, Jonathan M Pell, Lindsie Stephan, Patrick P Kneeland, Heidi L Wald.   

Abstract

PROBLEM: The morbidity and mortality (M&M) conference is a vital event that can affect medical education, quality improvement, and peer review in academic departments. Historically, M&M conferences have emphasized cases that highlight diagnostic uncertainty or complex management conundrums. In this report, the authors describe the development, pilot, and refinement of a systems-based M&M conference model that combines the educational and clinical missions of improving quality and patient safety in the University of Colorado Department of Medicine. APPROACH: In 2011, a focused taskforce completed a literature review that informed the development of a framework for the redesigned systems-based M&M conference. The new model included a restructured monthly conference, longitudinal curriculum for residents, and formal channels for interaction with clinical effectiveness departments. Each conference features an in-depth discussion of an adverse event using specific quality improvement tools. Areas for improvement and suggested action items are identified during the conference and delegated to the relevant clinical departments. OUTCOMES: The new process has enabled the review of 27 adverse events over two years. Sixty-three action items were identified, and 33 were pursued. An average of 50 to 60 individuals participate in each conference, including interprofessional and interdisciplinary colleagues. Resident and faculty feedback regarding the new format has been positive, and other departments are starting to adopt this model. NEXT STEPS: A more robust process for identifying and selecting cases to discuss is needed, as is a stable, sufficient mechanism to manage the improvement initiatives that come out of each conference.

Entities:  

Mesh:

Year:  2016        PMID: 26983075     DOI: 10.1097/ACM.0000000000001150

Source DB:  PubMed          Journal:  Acad Med        ISSN: 1040-2446            Impact factor:   6.893


  7 in total

1.  Bridging Leadership Roles in Quality and Patient Safety: Experience of 6 US Academic Medical Centers.

Authors:  Jennifer S Myers; Anjala V Tess; Katherine McKinney; Glenn Rosenbluth; Vineet M Arora; Darlene Tad-Y; Arpana R Vidyarthi
Journal:  J Grad Med Educ       Date:  2017-02

2.  Analysis of the Interprofessional Clinical Learning Environment for Quality Improvement and Patient Safety From Perspectives of Interprofessional Teams.

Authors:  Mike K W Cheng; Sally Collins; Robert B Baron; Christy K Boscardin
Journal:  J Grad Med Educ       Date:  2021-12-14

3.  Neurology Morbidity and Mortality Conferences and Quality Improvement: Single-Center Experience and National Survey.

Authors:  Sophia L Ryan; Kathleen E McKee; Lizbeth Londono-Sanchez; Sarah Dougherty; Aneesh B Singhal
Journal:  Neurohospitalist       Date:  2022-02-10

4.  Two-Year Profile of Preventable Errors in Hospital-Based Neurology.

Authors:  Ariel Marks; Courtney Takahashi; Pria Anand; K H Vincent Lau
Journal:  Neurol Clin Pract       Date:  2022-06

5.  A Systems-Based Morbidity and Mortality Conference Was Associated With a Transient Reduction in ECG Completion Times.

Authors:  Andrew E Levy; Melanie D Whittington; Tyler J Anstett; Steven T Simon; Allen Wentworth; James E Carter; P Michael Ho
Journal:  Qual Manag Health Care       Date:  2021-10-29       Impact factor: 1.147

Review 6.  Quality Improvement Focused Morbidity and Mortality Rounds: An Integrative Review.

Authors:  Kayla P Churchill; Justin Murphy; Nick Smith
Journal:  Cureus       Date:  2020-12-18

7.  Implementation status of morbidity and mortality conferences in Swiss hospitals: a national cross-sectional survey study.

Authors:  Isabelle Praplan-Rudaz; Yvonne Pfeiffer; David L B Schwappach
Journal:  Int J Qual Health Care       Date:  2018-05-01       Impact factor: 2.038

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.